One in five lung cancer sufferers have a particularly virulent strain called small cell lung cancer which kills all but three per cent of sufferers within five years of diagnoses.
1/5的癌症患者带有一种特别的有毒病株，称为小细胞肺癌，这种肺癌五年内杀死了近3%的确诊患者。
Prof Seckl said: "I have been working on small cell lung cancer for many years and to find something that can take a measurable piece of tumour and make it go away is wonderful.
塞克尔教授说：“我研究小细胞肺癌多年，发现能够消除大块肿瘤并使之消失是件美妙的事。”
Pfizer’s crizotinib attacks a protein encoded by a gene found in fewer than 5% of patients with non-small-cell lung cancer.
辉瑞公司的crizotinib攻击某种蛋白质，这种蛋白质由在不到5%的非小细胞肺癌患者中发现的一种基因编码。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
Conclusion FHIT gene may play a role in the regulation of cell proliferation of lung cancer, and the reduction in FHIT expression may be related to the pathogenesis of lung cancer.
结论FHIT基因可能参与肿瘤细胞增殖的调控，FHIT基因表达下降可能与肺癌的发生密切相关。
The standard treatment of advanced non-small cell lung cancer is plain-based combination chemotherapy, and the efficacy of chemotherapy reaches a plateau.
晚期非小细胞肺癌的标准治疗是以铂类为基础的联合化疗，化疗的疗效达到平台。
Conclusion Stereotacitic radiotherapy (whole body gamma knife) is a safe and effective way for the treatment of early non small cell lung cancer with less side effect.
结论体部伽玛刀治疗非小细胞肺癌有较好近期疗效，不良反应少且轻。
Thoracic radiotherapy has been a key component of local treatment for the patients with non small cell lung cancer(NSCLC).
放疗仍是非小细胞肺癌（NSCLC）重要的局部治疗手段。
ConclusionThe lung cancer associated antigen N35 might be an important tumor associated antigen and related with the proliferation of cancer cells as a role of tumor cell growth regulator.
结论肺癌相关抗原n 35是一种重要的肿瘤相关抗原，其功能很可能与肿瘤细胞无限制增殖活动有关。麦芽凝集素亲和层析法是纯化肺癌相关蛋白n 35简便有效的途径。
Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC).
吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
Small cell lung cancer, most malignant and highly aggressive has a high relapse rate due to drug resistance.
小细胞肺癌恶性程度高，早期易转移，虽对化疗敏感，但预后不佳，对药物耐药是其主要原因。
Others drugs Novartis aims to launch by 2011 are ASA404 for non-small-cell lung cancer, SOM230 for a rare group of neuroendocrine tumors and LBH589 for cutaneous T-cell lymphoma.
2011年前诺华公司想要发布的其他药物是治疗非小细胞肺癌的ASA404，治疗一种罕见消化系统神经内分泌癌的SOM230和治疗皮肤T细胞淋巴瘤的LBH589。
In many cases, non-small cell lung cancer and smoking, but a few of adenocarcinoma and large cell lung cancer led to most of the reasons are not clear.
友谊提醒两大肺癌类型：癌细胞在显微镜下表现出不同的形态特点，因此肺可分为两种主要类型分为：非小细胞肺癌，小细胞肺癌。这两种癌症的生长和扩散是不同的，治疗也明显不同。
Objective To support a reasonable and standard TCM treatment principle for advanced non-small-cell lung cancer (NSCLC) by exploring TCM syndrome features in NSCLC patients with factor analysis.
目的采用因子分析的方法，探讨晚期非小细胞肺癌（NSCLC）中医临床证候特征，为中医药合理规范化地参与晚期肺癌的治疗提供思路。
"This is a beginning of the ideal individualized treatment for metastatic non-small-cell lung cancer," said Inoue.
井上说：“这是一个理想的个体化治疗转移性非小细胞肺癌的开始。”
Yang JCH, et al. Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): updated results from BLOOM, a Phase I study.
osimertinib在非小细胞肺癌（NSCLC）所致软脑脊膜（LM）病患者（pts）中的活性：BLOOMI期研究的更新结果。
The strategy targeted to the tumor suppressor gene that regulates the cell cycle directly, obtained satisfactory results, and provided a reliable theory for lung cancer gene therapy.
本项基因治疗策略以直接调控细胞周期的抑癌基因为靶向治疗基因，为肺癌基因治疗提供了可靠的理论依据。
In addition, studies have shown that TACC3 could be useful as a prognostic marker for non-small cell lung cancer (8).
此外，研究发现TACC3是一个有效的非小细胞肺癌的预后标志物(8)。
Pfizer's crizotinib attacks a protein encoded by a gene found in fewer than 5% of patients with non-small-cell lung cancer.
Pfizer的crizotinib专门攻击某种基因转录的蛋白，只有少于5%的非小细胞肺癌患者具有这种基因。 Roche的vemurafenib通过阻断基因B-RAF的变异体抵抗晚期黑色素瘤。
The research on isolation and identification of lung cancer stem cell markers will provide a new strategy for the treatment of lung cancer.
但肿瘤干细胞学说的创立与研究使肺癌的根治成为了可能，现就目前肺癌干细胞标志物的研究进展作一系统性总结。
Objective To establish a successful xenotransplantation model of a human small cell lung cancer cell line (NCI_H446) in nude mice.
目的建立成瘤稳定、潜伏期短的人小细胞肺癌nci_h4 4 6细胞裸鼠移植瘤模型。
Objective To establish a successful xenotransplantation model of a human small cell lung cancer cell line (NCI_H446) in nude mice.
目的建立成瘤稳定、潜伏期短的人小细胞肺癌nci_h4 4 6细胞裸鼠移植瘤模型。
应用推荐